| HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis JA Pineda, M Romero‐Gómez, F Díaz‐García, JA Girón‐González, ... Hepatology 41 (4), 779-789, 2005 | 377 | 2005 |
| Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus J Macías, J Berenguer, MA Japón, JA Girón, A Rivero, LF López‐Cortés, ... Hepatology 50 (4), 1056-1063, 2009 | 320 | 2009 |
| Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy JA Pineda, JA García‐García, M Aguilar‐Guisado, MJ Ríos‐Villegas, ... Hepatology 46 (3), 622-630, 2007 | 260 | 2007 |
| Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease N Merchante, JA Girón-González, M González-Serrano, J Torre-Cisneros, ... Aids 20 (1), 49-57, 2006 | 239 | 2006 |
| The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection S Vergara, J Macías, A Rivero, A Gutiérrez-Valencia, M González-Serrano, ... Clinical infectious diseases 45 (8), 969-974, 2007 | 238 | 2007 |
| Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine J Macías, V Castellano, N Merchante, RB Palacios, JA Mira, C Sáez, ... Aids 18 (5), 767-774, 2004 | 222 | 2004 |
| HCV epidemiology in high-risk groups and the risk of reinfection H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ... Journal of hepatology 65 (1), S33-S45, 2016 | 219 | 2016 |
| Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors A Rivero, JA Mira, JA Pineda Journal of antimicrobial chemotherapy 59 (3), 342-346, 2007 | 176 | 2007 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 172 | 2021 |
| Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus JA Pineda, A Caruz, A Rivero, K Neukam, I Salas, A Camacho, P José C, ... Clinical Infectious Diseases 51 (7), 788-795, 2010 | 172 | 2010 |
| Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir E Vispo, P Barreiro, JA Pineda, JA Mira, I Maida, L Martín-Carbonero, ... Antiviral therapy 13 (3), 429-438, 2008 | 154 | 2008 |
| Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes J Macías, JA Girón-González, M González-Serrano, D Merino, P Cano, ... Gut 55 (3), 409-414, 2006 | 152 | 2006 |
| A common polymorphism in TLR3 confers natural resistance to HIV-1 infection M Sironi, M Biasin, R Cagliani, D Forni, M De Luca, I Saulle, S Lo Caputo, ... The Journal of Immunology 188 (2), 818-823, 2012 | 141 | 2012 |
| High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack J Macías, RB Palacios, E Claro, J Vargas, S Vergara, JA Mira, ... Liver International 28 (6), 781-786, 2008 | 136 | 2008 |
| Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin K Neukam, P Barreiro, J Macías, A Avellón, C Cifuentes, ... Clinical infectious diseases 57 (3), 465-468, 2013 | 135 | 2013 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 133 | 2019 |
| Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat … C Orkin, JM Molina, E Negredo, JR Arribas, J Gathe, JJ Eron, ... The Lancet HIV 5 (1), e23-e34, 2018 | 128 | 2018 |
| Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? FJ Medrano, J Hernández-Quero, E Jiménez, JA Pineda, A Rivero, ... Aids 6 (12), 1499-1504, 1992 | 117 | 1992 |
| Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosis JA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ... Clinical Infectious Diseases 56 (11), 1646-1653, 2013 | 112 | 2013 |
| Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy J Macias, I Melguizo, F Fernández-Rivera, A Garcia-Garcia, J Mira, ... European Journal of Clinical Microbiology and Infectious Diseases 21, 775-781, 2002 | 112 | 2002 |
